Literature DB >> 20812276

Use of Yokukansan (TJ-54) in the treatment of neurological disorders: a review.

S de Caires1, V Steenkamp.   

Abstract

Kampo herbal remedies are reported to have a wide range of indications and have attracted attention due to reports suggesting that these remedies are effective when used in disease treatment while maintaining a favourable quality of life. Yokukansan, also known as TJ-54, is composed of seven herbs; Angelica acutiloba, Atractylodes lancea, Bupleurum falcatum, Poria cocos, Glycyrrhiza uralensis, Cnidium officinale and Uncaria rhynchophylla. Yokukansan is used to treat insomnia and irritability as well as screaming attacks, sleep tremors and hypnic myoclonia, and neurological disorders which include dementia and Alzheimer's disease - the focus of this article. It is concluded that Yokukansan is a versatile herbal remedy with a variety of effects on various neurological states, without reported adverse effects. Traditional herbal medicines consist of a combination of constituents which account for the clinical effect seen. Likewise, the benefits of Yokukansan are probably attributable to the preparation as a whole, rather than to individual compounds. Copyright 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812276     DOI: 10.1002/ptr.3146

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  12 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

Review 2.  New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia.

Authors:  Fan-Chin Kung; Ryouhei Ishii; Hsing-Cheng Liu; Masatoshi Takeda
Journal:  Clin Interv Aging       Date:  2012-10-04       Impact factor: 4.458

3.  Traditional used Plants against Cognitive Decline and Alzheimer Disease.

Authors:  Gunter Peter Eckert
Journal:  Front Pharmacol       Date:  2010-12-08       Impact factor: 5.810

4.  History and experience: a survey of traditional chinese medicine treatment for Alzheimer's disease.

Authors:  Ping Liu; Mingwang Kong; Shihe Yuan; Junfeng Liu; Ping Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-29       Impact factor: 2.629

5.  Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion.

Authors:  Haruto Katahira; Masataka Sunagawa; Daishi Watanabe; Yasuaki Kanada; Ayami Katayama; Risa Yamauchi; Masashi Takashima; Shintaro Ishikawa; Tadashi Hisamitsu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-20       Impact factor: 2.570

6.  Yokukansan, a Kampo medicine, prevents the development of morphine tolerance through the inhibition of spinal glial cell activation in rats.

Authors:  Mariko Takemoto; Masataka Sunagawa; Mayumi Okada; Hideshi Ikemoto; Hiroki Suga; Ayami Katayama; Hiroshi Otake; Tadashi Hisamitsu
Journal:  Integr Med Res       Date:  2015-12-31

7.  Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats.

Authors:  Yasuaki Kanada; Ayami Katayama; Hideshi Ikemoto; Kana Takahashi; Mana Tsukada; Akio Nakamura; Shogo Ishino; Tadashi Hisamitsu; Masataka Sunagawa
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-06       Impact factor: 2.570

8.  Efficacy and safety of pharmacotherapy for Alzheimer's disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials.

Authors:  M Seibert; V Mühlbauer; J Holbrook; S Voigt-Radloff; S Brefka; D Dallmeier; M Denkinger; C Schönfeldt-Lecuona; S Klöppel; C A F von Arnim
Journal:  Alzheimers Res Ther       Date:  2021-07-16       Impact factor: 6.982

9.  Orengedoku-to augmentation in cases showing partial response to yokukan-san treatment: a case report and literature review of the evidence for use of these Kampo herbal formulae.

Authors:  Hideki Okamoto; Atsushi Chino; Yoshiro Hirasaki; Keigo Ueda; Masaomi Iyo; Takao Namiki
Journal:  Neuropsychiatr Dis Treat       Date:  2013-01-18       Impact factor: 2.570

Review 10.  Yokukansan and its ingredients as possible treatment options for schizophrenia.

Authors:  Chuan-Hsun Yu; Ryouhei Ishii; Shun-Chieh Yu; Masatoshi Takeda
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-01       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.